About this item:

58 Views | 28 Downloads

Author Notes:

Katherine E. Vest, katherine.vest@uc.edu

Hyojung J. Choo, hchoo2@emory.edu

KV and HC designed the study, performed experiments, analyzed data, and wrote and edited the manuscript. YZ and ChZ performed experiments, analyzed data, and wrote and edited the manuscript. CaZ, FW, AM, and TW performed experiments, analyzed data, and edited the manuscript.

The authors would like to acknowledge Grace K. Pavlath for providing support to KV and HC for the in vivo satellite cell proliferation experiments included in this manuscript.

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Research Funding:

This research was supported in part by funding from the National Institutes of Health (NIH) NIAMS (R01 AR071397).

Keywords:

  • Science & Technology
  • Life Sciences & Biomedicine
  • Cell Biology
  • Developmental Biology
  • oculopharyngeal muscular dystrophy
  • muscular dystrophy
  • dysphagia
  • PABPN1
  • satellite cells
  • craniofacial muscles
  • autophagy
  • MUSCLE STEM-CELLS
  • NUCLEAR INCLUSIONS
  • SKELETAL-MUSCLE
  • EXPRESSION
  • MYOPATHY
  • MUTATION
  • REPEAT
  • LIFE

Pharyngeal pathology in a mouse model of oculopharyngeal muscular dystrophy is associated with impaired basal autophagy in myoblasts

Tools:

Journal Title:

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY

Volume:

Volume 10

Publisher:

, Pages 986930-986930

Type of Work:

Article | Final Publisher PDF

Abstract:

Oculopharyngeal muscular dystrophy (OPMD) is a late-onset dominant disease that primarily affects craniofacial muscles. Despite the fact that the genetic cause of OPMD is known to be expansion mutations in the gene encoding the nuclear polyadenosine RNA binding protein PABPN1, the molecular mechanisms of pathology are unknown and no pharmacologic treatments are available. Due to the limited availability of patient tissues, several animal models have been employed to study the pathology of OPMD. However, none of these models have demonstrated functional deficits in the muscles of the pharynx, which are predominantly affected by OPMD. Here, we used a knock-in mouse model of OPMD, Pabpn1+/A17, that closely genocopies patients. In Pabpn1+/A17 mice, we detected impaired pharyngeal muscle function, and impaired pharyngeal satellite cell proliferation and fusion. Molecular studies revealed that basal autophagy, which is required for normal satellite cell function, is higher in pharynx-derived myoblasts than in myoblasts derived from limb muscles. Interestingly, basal autophagy is impaired in cells derived from Pabpn1+/A17 mice. Pabpn1 knockdown in pharyngeal myoblasts failed to recapitulate the autophagy defect detected in Pabpn1+/A17 myoblasts suggesting that loss of PABPN1 function does not contribute to the basal autophagy defect. Taken together, these studies provide the first evidence for pharyngeal muscle and satellite cell pathology in a mouse model of OPMD and suggest that aberrant gain of PABPN1 function contributes to the craniofacial pathology in OPMD.

Copyright information:

© 2022 Zhang, Zeuthen, Zhu, Wu, Mezzell, Whitlow, Choo and Vest.

This is an Open Access work distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/).
Export to EndNote